REG - PureTech Health PLC - Transaction in Own Shares
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240129:nRSc2592Ba&default-theme=true
RNS Number : 2592B PureTech Health PLC 29 January 2024
29 January 2024
PureTech Health plc
Transaction in Own Shares
PureTech Health PLC (the "Company") announces that it has purchased the
following number of its ordinary shares of one pence each through Jefferies
International Limited ("Jefferies"), as part of its Share Buyback Programme,
details of which were announced on 9 May 2022.
Date of purchase: 26 January 2024
Number of ordinary shares purchased: 71,561
Highest price paid per share: 201.00p
Lowest price paid per share: 196.80p
Volume weighted average price paid per share: 198.69p
PureTech intends to retain the purchased shares in treasury.
Following the above transaction, the Company will have 19,002,570 ordinary
shares in treasury and has 270,465,589 ordinary shares in issue (excluding
treasury shares). The total number of voting rights in the Company is
therefore 270,465,589 which may be used by shareholders in their calculations
to determine if they are required to notify their interest in, or a change to
their interest in, PureTech Health plc under the FCA's Disclosure Guidance and
Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as
incorporated into UK domestic law by the European Union (Withdrawal) Act 2018)
(the Market Abuse Regulation), detailed information about the individual
purchases is available below.
About PureTech Health
PureTech is a clinical-stage biotherapeutics company dedicated to giving life
to new classes of medicine to change the lives of patients with devastating
diseases. The Company has created a broad and deep pipeline through its
experienced research and development team and its extensive network of
scientists, clinicians and industry leaders that is being advanced both
internally and through its Founded Entities. PureTech's R&D engine has
resulted in the development of 27 therapeutics and therapeutic candidates,
including two (Plenity® and EndeavorRx®) that have received both U.S.
FDA clearance and European marketing authorization and a third (KarXT) that
has been filed for FDA approval. A number of these programs are being advanced
by PureTech or its Founded Entities in various indications and stages of
clinical development, including registration enabling studies. All of the
underlying programs and platforms that resulted in this pipeline of
therapeutic candidates were initially identified or discovered and then
advanced by the PureTech team through key validation points.
For more information, visit www.puretechhealth.com
(http://www.puretechhealth.com/) or connect with us on X, formerly known as
Twitter, @puretechh.
Contact:
PureTech
Investor Relations
IR@puretechhealth.com
Individual Transactions
Transaction Date Transaction Time Volume Price (GBp) Platform Transaction Reference Number
26/01/2024 08:12:50 1088 197 XLON 00387302568TRLO0.1.1
26/01/2024 08:12:50 1088 197 XLON 00387302569TRLO0.1.1
26/01/2024 08:14:42 168 197 CHIX 00387303250TRLO0.1.1
26/01/2024 08:32:03 410 198.6 XLON 00387311350TRLO0.1.1
26/01/2024 08:40:55 490 198.6 XLON 00387314295TRLO0.1.1
26/01/2024 08:40:55 214 198.6 XLON 00387314296TRLO0.1.1
26/01/2024 08:40:55 518 198.6 XLON 00387314297TRLO0.1.1
26/01/2024 10:04:52 1464 199 CHIX 00387341060TRLO0.1.1
26/01/2024 10:04:56 26 199.4 BATE 00387341113TRLO0.1.1
26/01/2024 10:05:50 828 199.2 BATE 00387341348TRLO0.1.1
26/01/2024 10:05:50 1108 199.2 BATE 00387341349TRLO0.1.1
26/01/2024 10:05:50 418 198.8 XLON 00387341350TRLO0.1.1
26/01/2024 10:05:50 69 198.8 XLON 00387341351TRLO0.1.1
26/01/2024 10:05:50 1145 198.8 XLON 00387341352TRLO0.1.1
26/01/2024 10:05:52 260 199.4 TRQX 00387341361TRLO0.1.1
26/01/2024 10:06:50 35 198.6 AQXE 00387341659TRLO0.1.1
26/01/2024 10:06:50 204 198.6 AQXE 00387341660TRLO0.1.1
26/01/2024 10:06:50 130 198.6 TRQX 00387341661TRLO0.1.1
26/01/2024 10:09:56 544 198.4 CHIX 00387342544TRLO0.1.1
26/01/2024 10:09:56 1632 198.4 XLON 00387342545TRLO0.1.1
26/01/2024 10:25:03 201 198.6 XLON 00387347418TRLO0.1.1
26/01/2024 11:04:06 1372 199 XLON 00387358970TRLO0.1.1
26/01/2024 11:14:02 412 199.6 XLON 00387361744TRLO0.1.1
26/01/2024 11:14:09 455 199.6 XLON 00387361779TRLO0.1.1
26/01/2024 11:14:15 290 199.6 XLON 00387361799TRLO0.1.1
26/01/2024 11:33:25 49 199.6 XLON 00387366713TRLO0.1.1
26/01/2024 11:39:52 361 199.6 AQXE 00387368456TRLO0.1.1
26/01/2024 11:43:06 100 199.6 XLON 00387369379TRLO0.1.1
26/01/2024 11:45:06 83 201 XLON 00387369928TRLO0.1.1
26/01/2024 11:46:08 544 200.5 CHIX 00387370175TRLO0.1.1
26/01/2024 11:47:07 239 200 AQXE 00387370424TRLO0.1.1
26/01/2024 11:47:07 758 200 BATE 00387370425TRLO0.1.1
26/01/2024 11:47:07 1632 200 XLON 00387370426TRLO0.1.1
26/01/2024 11:47:07 90 199.8 TRQX 00387370427TRLO0.1.1
26/01/2024 11:47:07 16 199.8 TRQX 00387370428TRLO0.1.1
26/01/2024 11:47:07 24 199.8 TRQX 00387370429TRLO0.1.1
26/01/2024 11:47:12 10638 200 XLON 00387370446TRLO0.1.1
26/01/2024 11:50:03 544 199.6 CHIX 00387371269TRLO0.1.1
26/01/2024 11:50:04 380 199.2 XLON 00387371270TRLO0.1.1
26/01/2024 12:51:43 1796 199.2 XLON 00387389797TRLO0.1.1
26/01/2024 12:51:43 544 199.2 CHIX 00387389798TRLO0.1.1
26/01/2024 12:51:52 239 199 AQXE 00387389834TRLO0.1.1
26/01/2024 13:24:07 93 199 BATE 00387398806TRLO0.1.1
26/01/2024 13:24:21 451 199 BATE 00387398877TRLO0.1.1
26/01/2024 13:24:21 192 199 AQXE 00387398876TRLO0.1.1
26/01/2024 13:24:21 974 199 XLON 00387398878TRLO0.1.1
26/01/2024 13:24:21 1202 199 XLON 00387398879TRLO0.1.1
26/01/2024 13:31:33 872 199 XLON 00387400904TRLO0.1.1
26/01/2024 13:41:10 1 199.2 XLON 00387403995TRLO0.1.1
26/01/2024 13:41:10 86 199.2 XLON 00387403996TRLO0.1.1
26/01/2024 14:20:10 544 199.4 CHIX 00387417141TRLO0.1.1
26/01/2024 14:28:54 544 198.8 CHIX 00387420101TRLO0.1.1
26/01/2024 14:28:54 291 198.8 CHIX 00387420102TRLO0.1.1
26/01/2024 14:36:33 12 198.8 CHIX 00387424704TRLO0.1.1
26/01/2024 14:37:54 182 198.8 AQXE 00387425353TRLO0.1.1
26/01/2024 14:37:54 240 198.8 AQXE 00387425352TRLO0.1.1
26/01/2024 14:37:54 241 198.8 CHIX 00387425354TRLO0.1.1
26/01/2024 14:37:54 2375 198.8 XLON 00387425355TRLO0.1.1
26/01/2024 14:37:54 13 198.6 TRQX 00387425357TRLO0.1.1
26/01/2024 14:37:54 345 198.8 XLON 00387425356TRLO0.1.1
26/01/2024 14:37:54 29 198.6 TRQX 00387425358TRLO0.1.1
26/01/2024 14:37:54 59 198.6 TRQX 00387425359TRLO0.1.1
26/01/2024 14:37:54 29 198.6 TRQX 00387425360TRLO0.1.1
26/01/2024 14:37:54 15 198.6 TRQX 00387425361TRLO0.1.1
26/01/2024 14:37:54 115 198.6 TRQX 00387425362TRLO0.1.1
26/01/2024 14:38:05 544 198.2 BATE 00387425516TRLO0.1.1
26/01/2024 14:38:05 332 198.2 BATE 00387425517TRLO0.1.1
26/01/2024 14:42:02 421 198.8 XLON 00387428063TRLO0.1.1
26/01/2024 14:42:02 238 198.8 XLON 00387428064TRLO0.1.1
26/01/2024 14:42:02 407 198.8 XLON 00387428065TRLO0.1.1
26/01/2024 14:44:44 212 198.6 XLON 00387429568TRLO0.1.1
26/01/2024 14:44:44 421 198.6 XLON 00387429569TRLO0.1.1
26/01/2024 14:44:44 238 198.6 XLON 00387429570TRLO0.1.1
26/01/2024 14:44:49 214 198.6 XLON 00387429587TRLO0.1.1
26/01/2024 14:44:56 131 198.6 XLON 00387429623TRLO0.1.1
26/01/2024 14:45:03 75 198.6 XLON 00387429688TRLO0.1.1
26/01/2024 14:45:09 42 198.6 XLON 00387429725TRLO0.1.1
26/01/2024 14:45:11 32 198.6 XLON 00387429741TRLO0.1.1
26/01/2024 14:45:11 30 198.2 BATE 00387429745TRLO0.1.1
26/01/2024 14:45:11 54 198.2 BATE 00387429746TRLO0.1.1
26/01/2024 14:45:17 25 198.6 XLON 00387429829TRLO0.1.1
26/01/2024 14:45:22 21 198.6 XLON 00387429879TRLO0.1.1
26/01/2024 14:45:27 25 198.6 XLON 00387429951TRLO0.1.1
26/01/2024 14:50:50 167 198.2 XLON 00387433060TRLO0.1.1
26/01/2024 14:50:50 1500 198.2 XLON 00387433061TRLO0.1.1
26/01/2024 14:50:50 1053 198.2 XLON 00387433062TRLO0.1.1
26/01/2024 14:52:50 2720 198 XLON 00387434589TRLO0.1.1
26/01/2024 14:52:51 406 197.8 XLON 00387434617TRLO0.1.1
26/01/2024 14:52:51 493 197.8 XLON 00387434616TRLO0.1.1
26/01/2024 14:52:51 400 198 XLON 00387434618TRLO0.1.1
26/01/2024 14:52:51 238 198 XLON 00387434619TRLO0.1.1
26/01/2024 14:56:49 1580 197.4 XLON 00387436613TRLO0.1.1
26/01/2024 14:56:49 500 197.4 XLON 00387436614TRLO0.1.1
26/01/2024 14:56:49 640 197.4 XLON 00387436615TRLO0.1.1
26/01/2024 15:01:51 100 197.4 XLON 00387439223TRLO0.1.1
26/01/2024 15:01:51 431 197.4 XLON 00387439224TRLO0.1.1
26/01/2024 15:01:51 421 197.4 XLON 00387439225TRLO0.1.1
26/01/2024 15:09:53 417 197.4 XLON 00387443373TRLO0.1.1
26/01/2024 15:09:53 547 197.4 XLON 00387443372TRLO0.1.1
26/01/2024 15:09:53 490 197.4 XLON 00387443374TRLO0.1.1
26/01/2024 15:16:44 544 197 CHIX 00387447148TRLO0.1.1
26/01/2024 15:16:44 220 197 AQXE 00387447149TRLO0.1.1
26/01/2024 15:16:44 40 197 XLON 00387447150TRLO0.1.1
26/01/2024 15:16:44 2136 197 XLON 00387447151TRLO0.1.1
26/01/2024 15:16:44 40 196.8 TRQX 00387447152TRLO0.1.1
26/01/2024 15:16:44 7 196.8 TRQX 00387447153TRLO0.1.1
26/01/2024 15:16:44 5 196.8 TRQX 00387447154TRLO0.1.1
26/01/2024 15:16:44 1 196.8 TRQX 00387447155TRLO0.1.1
26/01/2024 15:16:44 381 196.8 BATE 00387447156TRLO0.1.1
26/01/2024 15:16:44 291 196.8 BATE 00387447157TRLO0.1.1
26/01/2024 15:16:44 67 196.8 TRQX 00387447158TRLO0.1.1
26/01/2024 15:16:44 52 196.8 TRQX 00387447159TRLO0.1.1
26/01/2024 15:16:48 688 197 XLON 00387447199TRLO0.1.1
26/01/2024 15:17:48 612 197 XLON 00387447834TRLO0.1.1
26/01/2024 15:21:55 544 197 XLON 00387449994TRLO0.1.1
26/01/2024 15:35:04 311 197.8 XLON 00387456900TRLO0.1.1
26/01/2024 15:36:32 22 197.8 XLON 00387457789TRLO0.1.1
26/01/2024 15:36:32 833 197.8 XLON 00387457790TRLO0.1.1
26/01/2024 15:36:39 640 198 XLON 00387457836TRLO0.1.1
26/01/2024 15:55:15 52 198.2 XLON 00387474431TRLO0.1.1
26/01/2024 15:55:15 421 198.2 XLON 00387474432TRLO0.1.1
26/01/2024 15:55:15 32 198.2 XLON 00387474433TRLO0.1.1
26/01/2024 15:55:15 220 198.2 XLON 00387474434TRLO0.1.1
26/01/2024 15:56:19 659 198.4 XLON 00387475399TRLO0.1.1
26/01/2024 16:01:23 476 198.4 XLON 00387479092TRLO0.1.1
26/01/2024 16:01:27 665 198.4 XLON 00387479131TRLO0.1.1
26/01/2024 16:10:13 182 198.8 XLON 00387484505TRLO0.1.1
26/01/2024 16:10:20 1966 198.8 XLON 00387484581TRLO0.1.1
26/01/2024 16:15:17 72 198.8 XLON 00387488235TRLO0.1.1
26/01/2024 16:15:23 99 198.8 CHIX 00387488325TRLO0.1.1
26/01/2024 16:15:59 72 198.8 XLON 00387488865TRLO0.1.1
26/01/2024 16:16:00 45 198.8 CHIX 00387488884TRLO0.1.1
26/01/2024 16:16:02 20 198.8 XLON 00387488918TRLO0.1.1
26/01/2024 16:19:30 18 198.8 XLON 00387491809TRLO0.1.1
26/01/2024 16:20:53 239 198.8 AQXE 00387492856TRLO0.1.1
26/01/2024 16:20:53 18 198.8 XLON 00387492857TRLO0.1.1
26/01/2024 16:20:56 43 198.8 CHIX 00387492873TRLO0.1.1
26/01/2024 16:20:56 53 198.8 CHIX 00387492874TRLO0.1.1
26/01/2024 16:20:56 24 198.8 XLON 00387492875TRLO0.1.1
26/01/2024 16:21:02 35 198.8 XLON 00387492933TRLO0.1.1
26/01/2024 16:21:27 1 198.8 AQXE 00387493183TRLO0.1.1
26/01/2024 16:21:35 103 198.8 XLON 00387493298TRLO0.1.1
26/01/2024 16:21:51 352 198.8 XLON 00387493416TRLO0.1.1
26/01/2024 16:22:20 29 198.8 XLON 00387493660TRLO0.1.1
26/01/2024 16:27:58 133 199.8 XLON 00387497153TRLO0.1.1
26/01/2024 16:29:33 27 199.8 XLON 00387498443TRLO0.1.1
26/01/2024 16:29:37 13 200 CHIX 00387498601TRLO0.1.1
26/01/2024 16:29:38 544 200 XLON 00387498624TRLO0.1.1
26/01/2024 16:29:45 19 200 CHIX 00387498831TRLO0.1.1
26/01/2024 16:29:45 283 200 CHIX 00387498832TRLO0.1.1
26/01/2024 16:29:45 72 200 CHIX 00387498833TRLO0.1.1
26/01/2024 16:29:45 13 200 CHIX 00387498834TRLO0.1.1
26/01/2024 16:29:45 51 200 CHIX 00387498835TRLO0.1.1
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSFLFFSLRIAFIS
- Announcement
- Announcement
- Announcement
- Announcement
- Announcement